AIM: Although hematopoietic cell transplantation (HCT) arrests the cognitive decline in mucopolysaccharidosis type IH (Hurler syndrome, MPS IH), these children continue to have neuropsychological deficits as they age. Both compromised attention and effects on white matter have been observed in cancer patients who have had chemotherapy. Therefore, we explored the effects of disease and treatment on brain function in children with MPS I who have had HCT with those with attenuated MPS I treated with enzyme replacement therapy (ERT). SUBJECTS: 7 MPS IH participants at least 5 years post-HCT were compared with 7 attenuated participants who were treated with ERT. MEASURES: IQ, attention, spatial ability, and memory were assessed. Medical history and an unsedated MRI scan using diffusion tensor imaging (DTI) were acquired. RESULTS: Despite clinically equivalent IQ and memory, children with MPS IH had poorer attention span than those with attenuated MPS I as well as decreased fractional anisotropy (FA) of the corpus callosum. A relationship between attention scores and FA was found in the MPS IH group but not the attenuated group. FA was also related to the frequency of medical events. INTERPRETATION: In children with MPS IH, both the treatment and the disease affect attention functions associated with poor white matter integrity.
AIM: Although hematopoietic cell transplantation (HCT) arrests the cognitive decline in mucopolysaccharidosis type IH (Hurler syndrome, MPS IH), these children continue to have neuropsychological deficits as they age. Both compromised attention and effects on white matter have been observed in cancerpatients who have had chemotherapy. Therefore, we explored the effects of disease and treatment on brain function in children with MPS I who have had HCT with those with attenuated MPS I treated with enzyme replacement therapy (ERT). SUBJECTS: 7 MPS IHparticipants at least 5 years post-HCT were compared with 7 attenuated participants who were treated with ERT. MEASURES: IQ, attention, spatial ability, and memory were assessed. Medical history and an unsedated MRI scan using diffusion tensor imaging (DTI) were acquired. RESULTS: Despite clinically equivalent IQ and memory, children with MPS IH had poorer attention span than those with attenuated MPS I as well as decreased fractional anisotropy (FA) of the corpus callosum. A relationship between attention scores and FA was found in the MPS IH group but not the attenuated group. FA was also related to the frequency of medical events. INTERPRETATION: In children with MPS IH, both the treatment and the disease affect attention functions associated with poor white matter integrity.
Authors: Laura K Campbell; Mary Scaduto; William Sharp; Lynette Dufton; Deborah Van Slyke; James A Whitlock; Bruce Compas Journal: Pediatr Blood Cancer Date: 2007-07 Impact factor: 3.167
Authors: Wilburn E Reddick; Zuyao Y Shan; John O Glass; Susan Helton; Xiaoping Xiong; Shengjie Wu; Melanie J Bonner; Scott C Howard; Robbin Christensen; Raja B Khan; Ching-Hon Pui; Raymond K Mulhern Journal: Cancer Date: 2006-02-15 Impact factor: 6.860
Authors: G Souillet; N Guffon; I Maire; M Pujol; P Taylor; F Sevin; N Bleyzac; C Mulier; A Durin; K Kebaili; C Galambrun; Y Bertrand; R Froissart; C Dorche; L Gebuhrer; C Garin; J Berard; P Guibaud Journal: Bone Marrow Transplant Date: 2003-06 Impact factor: 5.483
Authors: Elsa G Shapiro; Igor Nestrasil; Kyle Rudser; Kathleen Delaney; Victor Kovac; Alia Ahmed; Brianna Yund; Paul J Orchard; Julie Eisengart; Gregory R Niklason; Julian Raiman; Eva Mamak; Morton J Cowan; Mara Bailey-Olson; Paul Harmatz; Suma P Shankar; Stephanie Cagle; Nadia Ali; Robert D Steiner; Jeffrey Wozniak; Kelvin O Lim; Chester B Whitley Journal: Mol Genet Metab Date: 2015-06-17 Impact factor: 4.797
Authors: Victor Kovac; Elsa G Shapiro; Kyle D Rudser; Bryon A Mueller; Julie B Eisengart; Kathleen A Delaney; Alia Ahmed; Kelly E King; Brianna D Yund; Morton J Cowan; Julian Raiman; Eva G Mamak; Paul R Harmatz; Suma P Shankar; Nadia Ali; Stephanie R Cagle; Jeffrey R Wozniak; Kelvin O Lim; Paul J Orchard; Chester B Whitley; Igor Nestrasil Journal: Mol Genet Metab Date: 2022-01-07 Impact factor: 4.797
Authors: Charles H Vite; Igor Nestrasil; Anton Mlikotic; Jackie K Jens; Elizabeth M Snella; William Gross; Elsa G Shapiro; Victor Kovac; James M Provenzale; Steven Chen; Steven Q Le; Shih-hsin Kan; Shida Banakar; Raymond Y Wang; Mark E Haskins; N Matthew Ellinwood; Patricia I Dickson Journal: Comp Med Date: 2013-04 Impact factor: 0.982
Authors: James M Provenzale; Igor Nestrasil; Steven Chen; Shih-Hsin Kan; Steven Q Le; Jacqueline K Jens; Elizabeth M Snella; Kristen N Vondrak; Jennifer K Yee; Charles H Vite; David Elashoff; Lewei Duan; Raymond Y Wang; N Matthew Ellinwood; Miguel A Guzman; Elsa G Shapiro; Patricia I Dickson Journal: Exp Neurol Date: 2015-07-26 Impact factor: 5.330
Authors: Agnes H Chen; Paul Harmatz; Igor Nestrasil; Julie B Eisengart; Kelly E King; Kyle Rudser; Alexander M Kaizer; Alena Svatkova; Amy Wakumoto; Steven Q Le; Jacqueline Madden; Sarah Young; Haoyue Zhang; Lynda E Polgreen; Patricia I Dickson Journal: Mol Genet Metab Date: 2019-11-30 Impact factor: 4.797
Authors: Kelly E King; Kyle D Rudser; Igor Nestrasil; Victor Kovac; Kathleen A Delaney; Jeffrey R Wozniak; Bryon A Mueller; Kelvin O Lim; Julie B Eisengart; Eva G Mamak; Julian Raiman; Nadia Ali; Stephanie Cagle; Paul Harmatz; Chester B Whitley; Elsa G Shapiro Journal: Neurology Date: 2019-04-12 Impact factor: 9.910